scholarly journals Effects of Various Doses of Caffeine Ingestion on Intermittent Exercise Performance and Cognition

2020 ◽  
Vol 10 (9) ◽  
pp. 595 ◽  
Author(s):  
Cuicui Wang ◽  
Yuechuan Zhu ◽  
Cheng Dong ◽  
Zigui Zhou ◽  
Xinyan Zheng
Keyword(s):  
Stroop Task ◽  
Exercise Performance ◽  
Power Output ◽  
Intermittent Exercise ◽  
Peak Power Output ◽  
High Dose ◽  
Double Blind ◽  
Caffeine Ingestion ◽  
Positive Effects ◽  
The Mean

To date, no study has examined the effects of caffeine on prolonged intermittent exercise performance that imitates certain team-sports, and the suitable concentration of caffeine for improved intermittent exercise performance remains elusive. The purpose of the present cross-over, double-blind preliminary study was to investigate effects of low, moderate, and high doses of caffeine ingestion on intermittent exercise performance and cognition. Ten males performed a familiarization session and four experimental trials. Participants ingested capsules of placebo or caffeine (3, 6, or 9 mg/kg) at 1 h before exercise, rested quietly, and then performed cycling for 2 × 30 min. The cycling protocol consisted of maximal power pedaling for 5 s (mass × 0.075 kp) every minute, separated by unloaded pedaling for 25 s and rest for 30 s. At pre-ingestion of capsules, 1 h post-ingestion, and post-exercise, participants completed the Stroop task. The mean power-output (MPO), peak power-output (PPO), and response time (RT) in the Stroop task were measured. Only 3 mg/kg of caffeine had positive effects on the mean PPO and MPO; 3 mg/kg caffeine decreased RTs significantly in the incongruent and congruent conditions. These results indicate that the ingestion of low-dose caffeine had greater positive effects on the participants’ physical strength during prolonged intermittent exercise and cognition than moderate- or high-dose caffeine.

scholarly journals ADORA2A C Allele Carriers Exhibit Ergogenic Responses to Caffeine Supplementation

Nutrients ◽  
2020 ◽  
Vol 12 (3) ◽  
pp. 741 ◽  
Author(s):  
Jozo Grgic ◽  
Craig Pickering ◽  
David J. Bishop ◽  
Juan Del Coso ◽  
Brad J. Schoenfeld ◽  
...  
Keyword(s):  
Exercise Performance ◽  
Power Output ◽  
Adenosine Receptors ◽  
Double Blind Study ◽  
Acute Effects ◽  
Movement Velocity ◽  
Double Blind ◽  
Caffeine Ingestion ◽  
Individual Variations ◽  
Ergogenic Effects

Caffeine’s ergogenic effects on exercise performance are generally explained by its ability to bind to adenosine receptors. ADORA2A is the gene that encodes A2A subtypes of adenosine receptors. It has been suggested that ADORA2A gene polymorphisms may be responsible for the inter-individual variations in the effects of caffeine on exercise performance. In the only study that explored the influence of variation in ADORA2A—in this case, a common polymorphism (rs5751876)—on the ergogenic effects of caffeine on exercise performance, C allele carriers were identified as “non-responders” to caffeine. To explore if C allele carriers are true “non-responders” to the ergogenic effects of caffeine, in this randomized, double-blind study, we examined the acute effects of caffeine ingestion among a sample consisting exclusively of ADORA2A C allele carriers. Twenty resistance-trained men identified as ADORA2A C allele carriers (CC/CT genotype) were tested on two occasions, following the ingestion of caffeine (3 mg/kg) and a placebo. Exercise performance was evaluated with movement velocity, power output, and muscle endurance during the bench press exercise, countermovement jump height, and power output during a Wingate test. Out of the 25 analyzed variables, caffeine was ergogenic in 21 (effect size range: 0.14 to 0.96). In conclusion, ADORA2A (rs5751876) C allele carriers exhibited ergogenic responses to caffeine ingestion, with the magnitude of improvements similar to what was previously reported in the literature among samples that were not genotype-specific. Therefore, individuals with the CT/CC genotype may still consider supplementing with caffeine for acute improvements in performance.

scholarly journals High-Dose, Short-Duration, Early Valacyclovir Therapy for Episodic Treatment of Cold Sores: Results of Two Randomized, Placebo-Controlled, Multicenter Studies

2003 ◽  
Vol 47 (3) ◽  
pp. 1072-1080 ◽  
Author(s):  
Spotswood L. Spruance ◽  
Terry M. Jones ◽  
Mark M. Blatter ◽  
Mauricio Vargas-Cortes ◽  
Judy Barber ◽  
...  
Keyword(s):  
Day Treatment ◽  
High Dose ◽  
Herpes Labialis ◽  
Lesion Development ◽  
Multicenter Studies ◽  
Double Blind ◽  
Cold Sore ◽  
Treatment Groups ◽  
The Mean ◽  
Cold Sores

ABSTRACT Oral valacyclovir is better absorbed than oral acyclovir, increasing acyclovir bioavailability three- to fivefold. This provides the opportunity to explore whether high systemic acyclovir concentrations are effective in the treatment of cold sores (herpes labialis). Two randomized, double-blind, placebo-controlled studies were conducted. Subjects were provided with 2 g of valacyclovir twice daily for 1 day (1-day treatment), 2 g of valacyclovir twice daily for 1 day and then 1 g of valacyclovir twice daily for 1 day (2-day treatment), or a matching placebo and instructed to initiate treatment upon the first symptoms of a cold sore. In study 1, the median duration of the episode (primary endpoint) was reduced by 1.0 day (P = 0.001) with 1-day treatment and 0.5 days (P = 0.009) with 2-day treatment compared to placebo. Similarly, the mean duration of the episode was statistically significantly reduced by 1.1 days with 1-day treatment and 0.7 days with 2-day treatment compared to placebo. The proportion of subjects in whom cold sore lesion development was prevented and/or blocked was increased by 6.4% (P = 0.096) with 1-day treatment and 8.5% (P = 0.061) with 2-day treatment compared to placebo. The time to lesion healing and time to cessation of pain and/or discomfort were statistically significantly reduced with valacyclovir compared to placebo. In study 2, results similar to those in study 1 were obtained. AEs were similar across treatment groups. These studies provide evidence supporting a simple, 1-day valacyclovir treatment regimen for cold sores that is safe and effective. The 1-day valacyclovir regimen offers patients a unique and convenient dosing alternative compared to available topical therapies.

scholarly journals Anaerobic energy provision does not limit Wingate exercise performance in endurance-trained cyclists

2003 ◽  
Vol 94 (2) ◽  
pp. 668-676 ◽  
Author(s):  
J. A. L. Calbet ◽  
J. A. De Paz ◽  
N. Garatachea ◽  
S. Cabeza de Vaca ◽  
J. Chavarren
Keyword(s):  
Exercise Performance ◽  
Power Output ◽  
Acute Hypoxia ◽  
Lactate Concentration ◽  
Oxygen Deficit ◽  
Peak Power Output ◽  
Fatigue Index ◽  
Mean Power ◽  
Anaerobic Energy ◽  
Mean Power Output

The aim of this study was to evaluate the effects of severe acute hypoxia on exercise performance and metabolism during 30-s Wingate tests. Five endurance- (E) and five sprint- (S) trained track cyclists from the Spanish National Team performed 30-s Wingate tests in normoxia and hypoxia (inspired O2 fraction = 0.10). Oxygen deficit was estimated from submaximal cycling economy tests by use of a nonlinear model. E cyclists showed higher maximal O2 uptake than S (72 ± 1 and 62 ± 2 ml · kg−1 · min−1, P < 0.05). S cyclists achieved higher peak and mean power output, and 33% larger oxygen deficit than E ( P< 0.05). During the Wingate test in normoxia, S relied more on anaerobic energy sources than E ( P < 0.05); however, S showed a larger fatigue index in both conditions ( P < 0.05). Compared with normoxia, hypoxia lowered O2 uptake by 16% in E and S ( P < 0.05). Peak power output, fatigue index, and exercise femoral vein blood lactate concentration were not altered by hypoxia in any group. Endurance cyclists, unlike S, maintained their mean power output in hypoxia by increasing their anaerobic energy production, as shown by 7% greater oxygen deficit and 11% higher postexercise lactate concentration. In conclusion, performance during 30-s Wingate tests in severe acute hypoxia is maintained or barely reduced owing to the enhancement of the anaerobic energy release. The effect of severe acute hypoxia on supramaximal exercise performance depends on training background.

scholarly journals Acute ibuprofen ingestion does not attenuate fatigue during maximal intermittent knee extensor or all-out cycling exercise

2019 ◽  
Vol 44 (2) ◽  
pp. 208-215 ◽  
Author(s):  
Paul T. Morgan ◽  
Anni Vanhatalo ◽  
Joanna L. Bowtell ◽  
Andrew M. Jones ◽  
Stephen J. Bailey
Keyword(s):  
Exercise Performance ◽  
Power Output ◽  
Knee Extensor ◽  
Cycling Performance ◽  
Similar Rate ◽  
Cycle Ergometer ◽  
Knee Extensors ◽  
Mean Power ◽  
Healthy Humans ◽  
The Mean

Recent research suggests that acute consumption of pharmacological analgesics can improve exercise performance, but the ergogenic potential of ibuprofen (IBP) administration is poorly understood. This study tested the hypothesis that IBP administration would enhance maximal exercise performance. In one study, 13 physically active males completed 60 × 3-s maximal voluntary contractions (MVCs) of the knee extensors interspersed with 2-s passive recovery periods, on 2 occasions, with the critical torque (CT) estimated as the mean torque over the last 12 contractions (part A). In another study, 16 active males completed two 3-min all-out tests against a fixed resistance on an electronically braked cycle ergometer, with the critical power estimated from the mean power output over the final 30 s of the test (part B). All tests were completed 60 min after ingestion of maltodextrin (placebo, PL) or 400 mg of IBP. Peripheral nerve stimulation was administered at regular intervals and electromyography was measured throughout. For part A, mean torque (IBP: 60% ± 13% of pre-exercise MVC; PL: 58% ± 14% of pre-exercise MVC) and CT (IBP: 41% ± 16% of pre-exercise MVC; PL: 40% ± 15% of pre-exercise MVC) were not different between conditions (P > 0.05). For part B, end-test power output (IBP: 292 ± 28 W; PL: 288 ± 31 W) and work done (IBP: 65.9 ± 5.9 kJ; PL: 65.4 ± 6.4 kJ) during the 3-min all-out cycling tests were not different between conditions (all P > 0.05). For both studies, neuromuscular fatigue declined at a similar rate in both conditions (P > 0.05). In conclusion, acute ingestion of 400 mg of IBP does not improve single-leg or maximal cycling performance in healthy humans.

The Effects of Caffeine Mouth Rinsing on Exercise Performance: A Systematic Review

2020 ◽  
Vol 30 (5) ◽  
pp. 362-373
Author(s):  
Alex M. Ehlert ◽  
Hannah M. Twiddy ◽  
Patrick B. Wilson
Keyword(s):  
Exercise Performance ◽  
Systemic Absorption ◽  
Caffeine Intake ◽  
Mouth Rinse ◽  
Genetic Modifiers ◽  
Improve Performance ◽  
Caffeine Ingestion ◽  
Positive Effects ◽  
Negative Side Effects ◽  
Mouth Rinsing

Caffeine ingestion can improve performance across a variety of exercise modalities but can also elicit negative side effects in some individuals. Thus, there is a growing interest in the use of caffeine mouth rinse solutions to improve sport and exercise performance while minimizing caffeine’s potentially adverse effects. Mouth rinse protocols involve swilling a solution within the oral cavity for a short time (e.g., 5–10 s) before expectorating it to avoid systemic absorption. This is believed to improve performance via activation of taste receptors and stimulation of the central nervous system. Although reviews of the literature indicate that carbohydrate mouth rinsing can improve exercise performance in some situations, there has been no attempt to systematically review the available literature on caffeine mouth rinsing and its effects on exercise performance. To fill this gap, a systematic literature search of three databases (PubMed, SPORTDiscus, and Web of Science) was conducted by two independent reviewers. The search resulted in 11 randomized crossover studies that were appraised and reviewed. Three studies found significant positive effects of caffeine mouth rinsing on exercise performance, whereas the remaining eight found no improvements or only suggestive benefits. The mixed results may be due to heterogeneity in the methods across studies, interindividual differences in bitter tasting, and differences in the concentrations of caffeine solutions. Future studies should evaluate how manipulating the concentration of caffeine solutions, habitual caffeine intake, and genetic modifiers of bitter taste influence the efficacy of caffeine mouth rinsing as an ergogenic strategy.

Topographic Quantitative EEG Response to Acute Caffeine Withdrawal: A Comprehensive Analysis of Multiple Quantitative Variables

2002 ◽  
Vol 33 (4) ◽  
pp. 178-188 ◽  
Author(s):  
Roy R. Reeves ◽  
Frederick A. Struve ◽  
Gloria Patrick
Keyword(s):  
Quantitative Eeg ◽  
Comprehensive Analysis ◽  
Relative Power ◽  
Caffeine Consumption ◽  
Double Blind ◽  
Caffeine Ingestion ◽  
Absolute Power ◽  
Caffeine Withdrawal ◽  
The Mean ◽  
Abstinence Period

Most previous studies of the neurophysiological effects of caffeine have focused on the effects of caffeine ingestion, and few studies have examined the effects of caffeine withdrawal. This open study evaluated the quantitative EEG (QEEG) changes occurring during a 4-day period of abstinence in subjects who habitually consume 300 mg or more of caffeine daily. Thirteen subjects underwent QEEG studies during their usual caffeine consumption (baseline) and on days 1,2, and 4 of a 4-day period of caffeine abstinence. Ten of the subjects underwent a second QEEG on day 4 that consisted of a period of recording after reinstitution of caffeine. A comprehensive analysis of multiple quantitative variables was performed for each study during the abstinence period and compared to the variables obtained at baseline for each subject. Changes occurring during caffeine abstinence included: 1) increases in theta absolute power over all cortical areas, 2) increases in delta absolute power over the frontal cortex, 3) decreases in the mean frequency of both the alpha and beta rhythm, 4) increase in theta relative power and decrease in beta relative power, and 5) significant changes in interhemispheric coherence. Most of these changes tended to return to pre-abstinence baseline levels rapidly after resumption of caffeine consumption. The caffeine withdrawal state affects a number of neurophysiological variables. Further investigation of the neurophysiological aspects of caffeine withdrawal using placebo controlled double blind assessment methods is warranted.

Effects of Caffeine Ingestion on Exercise-induced Change during High-Intensity Intermittent Exercise

1995 ◽  
Vol 5 (1) ◽  
pp. 37-44 ◽  
Author(s):  
Isaiah Trice ◽  
Emily M. Haymes
Keyword(s):  
Blood Glucose ◽  
Perceived Exertion ◽  
Intermittent Exercise ◽  
Time To Exhaustion ◽  
Double Blind ◽  
Serum Free Fatty Acid ◽  
Caffeine Ingestion ◽  
Serum Free ◽  
Placebo Trial ◽  
Double Blind Design

In this study a double-blind design was used to determine the effect of caffeine on time to exhaustion and on associated metabolic and circulatory measures. Eight male subjects ingested either caffeine (5 mg/kg body weight) or a placebo 1 hr prior to exercise at 85-90% of maximum workload. Subjects were encouraged to complete three 30-min intermittent cycling periods at 70 rpm with 5 min rest between each. The exercise was terminated when the subject failed to complete three 30-min periods or failed to maintain 70 rpm for at least 15 s consecutively. Serum free fatty acids, glycerol, blood glucose, lactate, perceived exertion, heart rate, andcost were measured. The time to exhaustion was significantly longer during the caffeine trial than during the placebo trial. Serum free fatty acid levels were significantly different between trials. The decline in blood glucose levels was significantly less during the caffeine trial than during the placebo trial. There were no significant differences between trials for the other measures. It was concluded that caffeine increases time to exhaustion when trained subjects cycled intermittently at high levels of intensity.

N-acetylcysteine alters substrate metabolism during high-intensity cycle exercise in well-trained humans

2013 ◽  
Vol 38 (12) ◽  
pp. 1217-1227 ◽  
Author(s):  
Adam J. Trewin ◽  
Aaron C. Petersen ◽  
Francois Billaut ◽  
Leon R. McQuade ◽  
Bernie V. McInerney ◽  
...  
Keyword(s):  
Power Output ◽  
High Intensity ◽  
Repeated Measures ◽  
Vastus Lateralis ◽  
Venous Blood ◽  
Time Trial ◽  
Peak Power Output ◽  
Mean Power ◽  
Double Blind ◽  
Substrate Metabolism

We investigated the effects of N-acetylcysteine (NAC) on metabolism during fixed work rate high-intensity interval exercise (HIIE) and self-paced 10-min time-trial (TT10) performance. Nine well-trained male cyclists (V̇O2peak, 69.4 ± 5.8 mL·kg−1·min−1; peak power output (PPO), 385 ± 43 W; mean ± SD) participated in a double-blind, repeated-measures, randomised crossover trial. Two trials (NAC supplementation and placebo) were performed 7 days apart consisting of 6 × 5 min HIIE bouts at 82% PPO (316 ± 40 W) separated by 1 min at 100 W, and then after 2 min of recovery at 100 W, TT10 was performed. Expired gases, venous blood, and electromyographic (EMG) data were collected. NAC did not influence blood glutathione but decreased lipid peroxidation compared with the placebo (P < 0.05). Fat oxidation was elevated with NAC compared with the placebo during HIIE bouts 5 and 6 (9.9 ± 8.9 vs. 3.9 ± 4.8 μmol·kg−1·min−1; P < 0.05), as was blood glucose throughout HIIE (4.3 ± 0.6 vs. 3.8 ± 0.6 mmol·L−1; P < 0.05). Blood lactate was lower with NAC after TT10 (3.3 ± 1.3 vs. 4.2 ± 1.3 mmol·L−1; P < 0.05). Median EMG frequency of the vastus lateralis was lower with NAC during HIIE (79 ± 10 vs. 85 ± 10 Hz; P < 0.05), but not TT10 (82 ± 11 Hz). Finally, NAC decreased mean power output 4.9% ± 6.6% (effect size = –0.3 ± 0.4, mean ± 90% CI) during TT10 (305 ± 57 W vs. 319 ± 45 W). These data suggest that NAC alters substrate metabolism and muscle fibre type recruitment during HIIE, which is detrimental to time-trial performance.

scholarly journals Comparison of Serum Choline and Trimethylamine N-oxide after ingestion of Alpha Glyceryl Phosphoryl Choline and Choline Salts.

2021 ◽  
Vol 02 ◽  
Author(s):  
Greggory R. Davis ◽  
David Bellar ◽  
Randy L. Aldret
Keyword(s):  
Health Outcomes ◽  
Dietary Supplement ◽  
Exercise Performance ◽  
Low Dose ◽  
Choline Chloride ◽  
Serum Levels ◽  
High Dose ◽  
Concomitant Increase ◽  
Double Blind ◽  
Phosphoryl Choline

Background: Choline supplements may provide potential improvements to health outcomes and exercise performance, yet the bioavailability of choline supplements is poorly understood. Objective: The objective of the present investigation was to examine the levels of serum Choline and Trimethylamine N-oxide (TMAO) after two dose of Alpha Glyceryl Phosphoryl Choline (A-GPC) in comparison to common choline salts. Methods: High-dose and low-dose A-GPC along with choline salt supplements were administered to participants over the course of four weeks in a randomized double-blind fashion. Serum levels of choline and TMAO, the gut byproduct of choline were examined acutely over the course of four hours and again following one week and four weeks of supplementation. Results: High-dose A-GPC and the choline chloride supplement yielded significantly higher choline levels compared to low-dose A-GPC and choline bitartate (F=31.31, p<0.01) though the effect for time was not significant. TMAO levels were not significantly different between supplements (F=1.96. p=0.1361) or across time (F=0.0795, p=0.7795). Conclusion: A-GPC increases serum choline similar to that seen with high-dose choline chloride ingestion without a concomitant increase in TMAO levels and therefore, may be a desirable option as a dietary supplement.

Sign in / Sign up

Export Citation Format

Share Document